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background:  Although there have been few studies regarding the adverse effect of chronic kidney disease (CKD) on clinical outcomes in 
diabetic patients undergoing percutaneous coronary intervention (PCI), most studies were conducted in the era of bare metal stent or 1st 
generation drug-eluting stent (DES). It is expected that improvement in interventional techniques, use of new generation drug-eluting stent, 
and adherence of optimal medical therapy would improve interventional outcomes. Therefore, we evaluated the impact of CKD on clinical 
outcomes of diabetic patients who underwent PCI using newer generation DES in real world setting.
methods:  From ongoing single center registry that prospectively enrolls unselected patients undergoing PCI, 887 patients who were 
successfully implanted newer generation DES between Jan. 2011 and Dec. 2013 and had a history of DM or whose HbA1c was higher 
than 6.5mg/dl at the time of admission were analyzed. These patients were divided into two groups: patients without CKD (n = 549) and 
with CKD (n = 338). CKD was defined as eGFR of <60 ml/min using Cockcroft-Gault equation. Primary end point was a patient-oriented 
composite outcome (POCO) at 1-year of follow-up. POCO includes all-cause mortality, any MI, and any revascularization.
results:  Compared with patients without CKD, patients with CKD were older and more likely to be female and have a history of 
hypertension. These patients were more likely to have presented with a non-ST-segment elevation myocardial infarction. On angiography, 
multi-vessel disease was frequent and implanted stent diameter was smaller in these patients. During the index hospital admission, 
bleeding complication was frequent in patients with CKD (0.7% vs. 4.4%, p <0.001). POCO was also frequent in this group (6.6% vs. 
19.8%, Log-rank p <0.001). On multivariate analysis adjusted for baseline differences in demographic, clinical, and angiographic factors, 
presence of CKD (odd ratio: 1.83, 95% confidence interval: 1.123 to 2.989) was an independent predictor for POCO.
Conclusion:  CKD is an independent and powerful predictor for bleeding and worse clinical outcome in diabetic patients treated with PCI 
with new generation DES.
